Published in BMJ on February 04, 1989
School sex education: an experimental programme with educational and medical benefit. BMJ (1995) 3.76
Age, socio-economic status and survival from cancer of cervix in the West of Scotland 1980-87. Br J Cancer (1993) 2.57
Predicting mortality from cervical cancer after negative smear test results. BMJ (1992) 2.01
Intrinsic radiosensitivity and prediction of patient response to radiotherapy for carcinoma of the cervix. Br J Cancer (1993) 1.42
Young teenagers' attitudes towards general practitioners and their provision of sexual health care. Br J Gen Pract (2000) 1.16
Changing character of cervical cancer in young women. BMJ (1989) 1.09
Glutathione S-transferase (placental) as a marker of transformation in the human cervix uteri: an immunohistochemical study. Br J Cancer (1990) 1.07
Transience of cervical HPV infection in sexually active, young women with normal cervicovaginal cytology. Br J Cancer (1995) 0.97
The increasing frequency of cervical cancer in Korean women under 35. Cancer Res Treat (2008) 0.93
A study of association between expression of hOGG1, VDAC1, HK-2 and cervical carcinoma. J Exp Clin Cancer Res (2010) 0.87
Prevalence, viral load, and physical status of HPV 16 and 18 in cervical adenosquamous carcinoma. Virchows Arch (2009) 0.87
XH1--a new cervical carcinoma cell line and xenograft model of tumour invasion, 'metastasis' and regression. Br J Cancer (1991) 0.85
Increased activity of 6-phosphogluconate dehydrogenase and glucose-6-phosphate dehydrogenase in purified cell suspensions and single cells from the uterine cervix in cervical intraepithelial neoplasia. Br J Cancer (1992) 0.84
A Population-based Study of Invasive Cervical Cancer Patients in Beijing: 1993-2008. Chin Med J (Engl) (2015) 0.82
Granuloma inguinale of the cervix: a carcinoma look-alike. Genitourin Med (1990) 0.79
Comprehensive clinic-pathological characteristics of cervical cancer in southwestern China and the clinical significance of histological type and lymph node metastases in young patients. PLoS One (2013) 0.78
Changing character of cervical cancer in young women. BMJ (1989) 0.75
Changing patterns of cervical cancer rates. Br Med J (Clin Res Ed) (1983) 2.73
Mortality from carcinoma of cervix uteri in Britain. Lancet (1978) 2.71
Mortality from carcinoma of the cervix. Lancet (1978) 2.54
Puzzling changes in cervical cancer in young women. Med J Aust (1987) 1.56
Cervical carcinoma: prognosis in younger patients. Br Med J (Clin Res Ed) (1987) 1.50
Invasive carcinoma of the cervix in Queensland. Change in incidence and mortality, 1959-1980. Med J Aust (1983) 1.24
U.S. trends in mortality from carcinoma of cervix. Lancet (1979) 1.20
The influence of nicotine abuse and diabetes mellitus on the results of primary irradiation in the treatment of carcinoma of the cervix. Cancer (1987) 1.19
Invasive cervical carcinoma in young women. Gynecol Oncol (1979) 1.17
Carcinoma of the cervix in the young patient. Obstet Gynecol (1977) 1.12
Combination chemotherapy followed by surgery or radiotherapy in patients with locally advanced cervical cancer. Br J Obstet Gynaecol (1987) 1.07
Rising cervical cancer mortality in young New Zealand women. N Z Med J (1979) 1.04
Trends in cervical cancer in New Zealand. N Z Med J (1986) 1.03
Cervical carcinoma in women aged 34 and younger. Am J Obstet Gynecol (1986) 1.02
The influence of patients' age and tumor grade on the prognosis of carcinoma of the cervix. Cancer (1983) 1.01
Carcinoma of the uterine cervix FIGO Stage I-B. Gynecol Oncol (1982) 0.93
Age and prognosis in stage Ib squamous cell carcinoma of the uterine cervix. Gynecol Oncol (1983) 0.93
Invasive cervical cancer in young women. Br J Obstet Gynaecol (1984) 0.90
Comprehensive human genetic maps: individual and sex-specific variation in recombination. Am J Hum Genet (1998) 19.35
Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol (2011) 13.95
Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev (2001) 10.02
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Ann Oncol (2013) 9.68
Cdc25 mitotic inducer targeted by chk1 DNA damage checkpoint kinase. Science (1997) 9.30
Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009. Ann Oncol (2009) 9.18
cdc25+ functions as an inducer in the mitotic control of fission yeast. Cell (1986) 8.82
Negative regulation of mitosis by wee1+, a gene encoding a protein kinase homolog. Cell (1987) 8.76
Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial. Lancet (2007) 8.08
Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007. Ann Oncol (2007) 7.33
Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol (2005) 5.41
Nuclear localization of Cdc25 is regulated by DNA damage and a 14-3-3 protein. Nature (1999) 5.38
Mus81-Eme1 are essential components of a Holliday junction resolvase. Cell (2001) 5.37
Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer. J Clin Oncol (2001) 5.31
Dephosphorylation and activation of a p34cdc2/cyclin B complex in vitro by human CDC25 protein. Nature (1991) 4.54
Redressing the balance--the ethics of not entering an eligible patient on a randomised clinical trial. Ann Oncol (1992) 4.41
On the receiving end--patient perception of the side-effects of cancer chemotherapy. Eur J Cancer Clin Oncol (1983) 4.35
Replication checkpoint enforced by kinases Cds1 and Chk1. Science (1998) 4.22
Cloning and characterization of a novel bicoid-related homeobox transcription factor gene, RIEG, involved in Rieger syndrome. Nat Genet (1996) 4.21
Cell-cycle control linked to extracellular environment by MAP kinase pathway in fission yeast. Nature (1995) 4.17
Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene. Nat Genet (1997) 4.16
Association of genetic variation of the transforming growth factor-alpha gene with cleft lip and palate. Am J Hum Genet (1989) 4.13
Fission yeast p107wee1 mitotic inhibitor is a tyrosine/serine kinase. Nature (1991) 3.86
The mitotic inducer nim1+ functions in a regulatory network of protein kinase homologs controlling the initiation of mitosis. Cell (1987) 3.82
Conjugation, meiosis, and the osmotic stress response are regulated by Spc1 kinase through Atf1 transcription factor in fission yeast. Genes Dev (1996) 3.81
Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer? Lancet (2000) 3.79
Communicating prognosis in early breast cancer: do women understand the language used? Med J Aust (1999) 3.76
RFLPs for transforming growth factor alpha (TGFA) gene at 2p13. Nucleic Acids Res (1986) 3.72
p80cdc25 mitotic inducer is the tyrosine phosphatase that activates p34cdc2 kinase in fission yeast. EMBO J (1991) 3.55
Randomised comparison of procedures for obtaining informed consent in clinical trials of treatment for cancer. Br Med J (Clin Res Ed) (1986) 3.52
The dynamics of change: cancer patients' preferences for information, involvement and support. Ann Oncol (1997) 3.50
A collection of tri- and tetranucleotide repeat markers used to generate high quality, high resolution human genome-wide linkage maps. Hum Mol Genet (1995) 3.44
Human Wee1 kinase inhibits cell division by phosphorylating p34cdc2 exclusively on Tyr15. EMBO J (1993) 3.30
Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience. Ann Oncol (2004) 3.29
Damage tolerance protein Mus81 associates with the FHA1 domain of checkpoint kinase Cds1. Mol Cell Biol (2000) 3.27
Activation and regulation of the Spc1 stress-activated protein kinase in Schizosaccharomyces pombe. Mol Cell Biol (1996) 3.18
Human Mus81-associated endonuclease cleaves Holliday junctions in vitro. Mol Cell (2001) 3.18
Integrated human genome-wide maps constructed using the CEPH reference panel. Nat Genet (1994) 3.06
Recombinant ATM protein complements the cellular A-T phenotype. Oncogene (1997) 2.95
Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials. Lancet (2008) 2.91
Regulation of mitosis by cyclic accumulation of p80cdc25 mitotic inducer in fission yeast. Nature (1990) 2.86
Mutations truncating the EP300 acetylase in human cancers. Nat Genet (2000) 2.84
Apoptosis: final common pathway of photoreceptor death in rd, rds, and rhodopsin mutant mice. Neuron (1993) 2.83
The role of nonlymphoid accessory cells in the immune response to different antigens. J Exp Med (1970) 2.82
A novel homeobox gene PITX3 is mutated in families with autosomal-dominant cataracts and ASMD. Nat Genet (1998) 2.82
Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG). Ann Oncol (2006) 2.72
Complete sequencing shows a role for MSX1 in non-syndromic cleft lip and palate. J Med Genet (2003) 2.72
Polymorphic human glucose transporter gene (GLUT) is on chromosome 1p31.3----p35. Diabetes (1987) 2.72
Human homolog of fission yeast cdc25 mitotic inducer is predominantly expressed in G2. Proc Natl Acad Sci U S A (1990) 2.71
Sharing decisions in cancer care. Soc Sci Med (2001) 2.70
Phosphorylation and association with the transcription factor Atf1 regulate localization of Spc1/Sty1 stress-activated kinase in fission yeast. Genes Dev (1998) 2.68
Linkage disequilibrium and evolutionary relationships of DNA variants (restriction enzyme fragment length polymorphisms) at the serum albumin locus. Proc Natl Acad Sci U S A (1984) 2.64
Mrc1 channels the DNA replication arrest signal to checkpoint kinase Cds1. Nat Cell Biol (2001) 2.62
Costs and benefits of adjuvant therapy in breast cancer: a quality-adjusted survival analysis. J Clin Oncol (1989) 2.57
Cdc2 tyrosine phosphorylation is required for the DNA damage checkpoint in fission yeast. Genes Dev (1997) 2.57
Cell cycle regulation of human WEE1. EMBO J (1995) 2.56
Pharmacokinetic profile of levofloxacin following once-daily 500-milligram oral or intravenous doses. Antimicrob Agents Chemother (1997) 2.44
Genetically engineered large animal model for studying cone photoreceptor survival and degeneration in retinitis pigmentosa. Nat Biotechnol (1997) 2.42
Dual functions of CDC6: a yeast protein required for DNA replication also inhibits nuclear division. EMBO J (1992) 2.41
Chk1 and Cds1: linchpins of the DNA damage and replication checkpoint pathways. J Cell Sci (2000) 2.37
Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies. N Engl J Med (1987) 2.37
Randomized clinical trials in oncology: understanding and attitudes predict willingness to participate. J Clin Oncol (2001) 2.34
Nim1 kinase promotes mitosis by inactivating Wee1 tyrosine kinase. Nature (1993) 2.30
MSX1, PAX9, and TGFA contribute to tooth agenesis in humans. J Dent Res (2004) 2.26
Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy? Ann Oncol (2008) 2.26
Mechanical stretch alters the actin cytoskeletal network and signal transduction in human trabecular meshwork cells. Invest Ophthalmol Vis Sci (1998) 2.19
A new improved sub-unit vaccine for plague: the basis of protection. FEMS Immunol Med Microbiol (1995) 2.16
The many faces and factors of orofacial clefts. Hum Mol Genet (1999) 2.16
Counteractive roles of protein phosphatase 2C (PP2C) and a MAP kinase kinase homolog in the osmoregulation of fission yeast. EMBO J (1995) 2.14
Cdc25 inhibited in vivo and in vitro by checkpoint kinases Cds1 and Chk1. Mol Biol Cell (1999) 2.14
Promoting patient participation and shortening cancer consultations: a randomised trial. Br J Cancer (2001) 2.13
The cdc25 M-phase inducer: an unconventional protein phosphatase. Cell (1992) 2.12
Desmoplastic and desmoplastic neurotropic melanoma: experience with 280 patients. Cancer (1998) 2.12
Mitotic DNA damage and replication checkpoints in yeast. Curr Opin Cell Biol (1998) 2.11
p55CDC25 is a nuclear protein required for the initiation of mitosis in human cells. Proc Natl Acad Sci U S A (1991) 2.10
Patient participation in the cancer consultation: evaluation of a question prompt sheet. Ann Oncol (1994) 2.09
The CEPH consortium linkage map of human chromosome 1. Genomics (1991) 2.09
Discrete roles of the Spc1 kinase and the Atf1 transcription factor in the UV response of Schizosaccharomyces pombe. Mol Cell Biol (1997) 2.07
A role for Hsp90 in cell cycle control: Wee1 tyrosine kinase activity requires interaction with Hsp90. EMBO J (1994) 2.07
Schizosaccharomyces pombe and Saccharomyces cerevisiae: a look at yeasts divided. Cell (1986) 2.06
Characteristics of an established cell line of retinoblastoma. J Natl Cancer Inst (1974) 2.05
Effect of pregnancy on overall survival after the diagnosis of early-stage breast cancer. J Clin Oncol (2001) 2.05
Genome-wide association scan for childhood caries implicates novel genes. J Dent Res (2011) 2.05
Active immunization with recombinant V antigen from Yersinia pestis protects mice against plague. Infect Immun (1995) 2.04
On the receiving end. V: Patient perceptions of the side effects of cancer chemotherapy in 1993. Ann Oncol (1996) 2.03
Domain-specific mutations in TGFB1 result in Camurati-Engelmann disease. Nat Genet (2000) 2.02
Initial therapy with combination of five antibiotics in febrile patients with leukaemia and neutropenia. Lancet (1972) 1.96
Computer-based interaction analysis of the cancer consultation. Br J Cancer (1995) 1.93
Pitx2, a bicoid-type homeobox gene, is involved in a lefty-signaling pathway in determination of left-right asymmetry. Cell (1998) 1.93
Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII. J Clin Oncol (2000) 1.92
Identifying breast cancer patients at high risk for bone metastases. J Clin Oncol (2000) 1.91
Molecular genetics of human serum albumin: restriction enzyme fragment length polymorphisms and analbuminemia. Proc Natl Acad Sci U S A (1983) 1.89
Association of MSX1 and TGFB3 with nonsyndromic clefting in humans. Am J Hum Genet (1998) 1.89
Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. The EORTC international antimicrobial therapy project group. J Infect Dis (1978) 1.89
Epidermal cells adhere preferentially to type IV (basement membrane) collagen. J Cell Biol (1979) 1.86